Association between prescribed antidepressants and other prescribed drugs differ by gender: a nationwide register-based study in Sweden

References

• Alonso J, Angermeyer MC, Bernert S, et al. Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109:21–7.
   Web of Science ®Google Scholar
• Alonso J, Angermeyer MC, Bernert S, et al. Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand. 2004;109:55–64.
   PubMed Web of Science ®Google Scholar
• Johansson R, Carlbring P, Heedman A, et al. Depression, anxiety and their comorbidity in the Swedish general population: point prevalence and the effect on health-related quality of life. PeerJ. 2013;1:e98.
   PubMed Web of Science ®Google Scholar
• Lejtzen N, Sundquist J, Sundquist K, et al. Depression and anxiety in Swedish primary health care: prevalence, incidence, and risk factors. Eur Arch Psychiatry Clin Neurosci. 2014;264:235–245. AprPubMed PMID: 23828500.
   PubMed Web of Science ®Google Scholar
• Kasteenpohja T, Marttunen M, Aalto ST, et al. Outcome of depressive and anxiety disorders among young adults: results from the Longitudinal Finnish Health 2011 Study. Nord J Psychiatry. 2018;72:205–213.
   PubMed Web of Science ®Google Scholar
• The National Board of Health and Welfare. Stockholm: The National Board of Health and Welfare. Official statistics of Sweden. Statistics-Health and Medical Care. Pharmaceuticals-statistics for 2016. 2016.
   Google Scholar
• Gardarsdottir H, Heerdink ER, van Dijk L, et al. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord. 2007;98:109–115.
   PubMed Web of Science ®Google Scholar
• Päären A, Knorring L, Jonsson U, et al. Drug prescriptions of adults with adolescent depression in a community sample. Pharmacoepidemiol Drug Saf. 2012;21:130–136.
   PubMed Web of Science ®Google Scholar
• Schmitz N, Kruse J. The relationship between mental disorders and medical service utilization in a representative community sample. Soc Psychiatry Psychiatr Epidemiol. 2002;37:380–386. AugPubMed PMID: 12195545.
   PubMed Web of Science ®Google Scholar
• Lykkegaard Soerensen A, Nielsen LP, Klindt Poulsen B, et al. Potentially inappropriate prescriptions in patients admitted to a psychiatric hospital. Nord J Psychiatry. 2016;70(5):365–373.
   PubMed Web of Science ®Google Scholar
• Katon W, Ciechanowski P. Impact of major depression on chronic medical illness. J Psychosom Res. 2002;53:859–863.
   PubMed Web of Science ®Google Scholar
• Moussavi S, Chatterji S, Verdes E, et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–858.
   PubMed Web of Science ®Google Scholar
• Sobel RM, Markov D. The impact of anxiety and mood disorders on physical disease: the worried not-so-well. Curr Psychiatry Rep. 2005;7:206–212.
   PubMedGoogle Scholar
• Stordal E, Bjelland I, Dahl AA, et al. individuals with somatic health problems. The Nord-Trondelag Health Study (HUNT). Scand J Prim Health Care. 2003;21:136–141.
   PubMed Web of Science ®Google Scholar
• Demyttenaere K, Bruffaerts R, Lee S, et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain. 2007;129:332–342.
   PubMed Web of Science ®Google Scholar
• Ormel J, Von Korff M, Burger H, et al. Mental disorders among persons with heart disease - results from World Mental Health surveys. Gen Hosp Psychiatry. 2007;29:325–334.
   PubMed Web of Science ®Google Scholar
• Høj Jørgensen TS, Mårtensson S, Ibfelt EH, et al. Time trend in depression diagnoses among acute coronary syndrome patients and a reference population from 2001 to 2009 in Denmark. Nord J Psychiatry. 2016;70(5):335–341.
   PubMed Web of Science ®Google Scholar
• Henningsen P, Zimmermann T, Sattel H. Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review. Psychosom Med. 2003;65:528–533.
   PubMed Web of Science ®Google Scholar
• Van Oudenhove L, Aziz Q. The role of psychosocial factors and psychiatric disorders in functional dyspepsia. Nat Rev Gastroenterol Hepatol. 2013;10:158–167.
   PubMed Web of Science ®Google Scholar
• Muller MJ, Kundermann B, Cabanel N. Eveningness and poor sleep quality independently contribute to self-reported depression severity in psychiatric inpatients with affective disorder. Nord J Psychiatry. 2016;70:329–334.
   PubMed Web of Science ®Google Scholar
• Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry. 2007;29:147–155.
   PubMed Web of Science ®Google Scholar
• Auvinen P, Mäntyselkä P, Koponen H, et al. Prevalence of restless legs symptoms according to depressive symptoms and depression type: a cross-sectional study. Nord J Psychiatry. 2018;72(1):51–56.
   PubMed Web of Science ®Google Scholar
• Saariaho AS, Saariaho TH, Mattila AK, et al. Alexithymia and depression in the recovery of chronic pain patients: a follow-up study. Nord J Psychiatry. 2017;71(4):262–269.
   PubMed Web of Science ®Google Scholar
• Bonnet F, Irving K, Terra JL, et al. Anxiety and depression are associated with unhealthy lifestyle in patients at risk of cardiovascular disease. Atherosclerosis. 2005;178:339–344.
   PubMed Web of Science ®Google Scholar
• Thunander Sundbom L, Bingefors K. The influence of symptoms of anxiety and depression on medication nonadherence and its causes: a population based survey of prescription drug users in Sweden. Patient Prefer Adherence. 2013;7:805–811.
   PubMed Web of Science ®Google Scholar
• Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci. 2002;25:154–159.
   PubMed Web of Science ®Google Scholar
• Gerrits MM, van Oppen P, van Marwijk HW, et al. The impact of chronic somatic diseases on the course of depressive and anxiety disorders. Psychother Psychosom. 2013;82:64–66. PubMed PMID:
   PubMed Web of Science ®Google Scholar
• Bingefors K, Isacson D. Epidemiology, co-morbidity, and impact on health-related quality of life of self-reported headache and musculoskeletal pain–a gender perspective. Eur J Pain. 2004;8:435–450.
   PubMed Web of Science ®Google Scholar
• Loikas D, Wettermark B, von Euler M, et al. Differences in drug utilisation between men and women: a cross-sectional analysis of all dispensed drugs in Sweden. BMJ Open. 2013;3(5):e002378.
   PubMed Web of Science ®Google Scholar
• Maher RL, Hanlon J, Hajjar ER. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2014;13:57–65.
   PubMed Web of Science ®Google Scholar
• Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993;8:278–283.
   PubMed Web of Science ®Google Scholar
• Wettermark B, Zoega H, Furu K, et al. The Nordic prescription databases as a resource for pharmacoepidemiological research–a literature review. Pharmacoepidemiol Drug Saf. 2013;22:691–699.
   PubMed Web of Science ®Google Scholar
• WHO. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology, Oslo. wwwwhoccno. 2005.
   Google Scholar
• Mortazavi SS, Shati M, Keshtkar A, et al. Defining polypharmacy in the elderly: a systematic review protocol. BMJ Open. 2016;6:e010989–27013600. PubMed PMID: Pubmed Central PMCID: 4809106.
   PubMed Web of Science ®Google Scholar
• Mercier A, Auger-Aubin I, Lebeau JP, et al. Evidence of prescription of antidepressants for non-psychiatric conditions in primary care: an analysis of guidelines and systematic reviews. BMC Family Practice. 2013;14:55.
   PubMed Web of Science ®Google Scholar
• Mojtabai R, Olfson M. Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Affairs. 2011;30:1434–1442.
   PubMed Web of Science ®Google Scholar
• Brilleman SL, Salisbury C. Comparing measures of multimorbidity to predict outcomes in primary care: a cross sectional study. Family Practice. 2013;30:172–178.
   PubMed Web of Science ®Google Scholar
• Henriksson S, Asplund R, Boethius G, et al. Infrequent use of antidepressants in depressed individuals (an interview and prescription database study in a defined Swedish population 2001-2002). Eur Psychiatry. 2006;21:355–360.
   PubMed Web of Science ®Google Scholar
• Lotfi L, Flyckt L, Krakau I, et al. Undetected depression in primary healthcare: occurrence, severity and co-morbidity in a two-stage procedure of opportunistic screening. Nord J Psychiatry. 2010;64:421–427.
   PubMed Web of Science ®Google Scholar
• Boyd A, Van de Velde S, Pivette M, et al. Gender differences in psychotropic use across Europe: results from a large cross-sectional, population-based study. Eur Psychiatry. 2015;30:778–788. SepPubMed PMID: 26052073.
   PubMed Web of Science ®Google Scholar
• Owens GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008;14:2–6.
   PubMed Web of Science ®Google Scholar
• Kovess-Masfety V, Boyd A, van de Velde S, et al. Are there gender differences in service use for mental disorders across countries in the European Union? Results from the EU-World Mental Health survey. J Epidemiol Community Health. 2014;68:649–656.
   PubMed Web of Science ®Google Scholar
• Hirshbein LD. Science, gender, and the emergence of depression in American psychiatry, 1952-1980. J Hist Med Allied Sci. 2006;61:187–216.
   PubMed Web of Science ®Google Scholar
• Skoog J, Midlov P, Beckman A, et al. Drugs prescribed by general practitioners according to age, gender and socioeconomic status after adjustment for multimorbidity level. BMC Family Practice. 2014;15:183.
   PubMed Web of Science ®Google Scholar
• Nordstrom A, Bodlund O. Every third patient in primary care suffers from depression, anxiety or alcohol problems. Nord J Psychiatry. 2008;62:250–255.
   PubMed Web of Science ®Google Scholar
• Tran C, Knowles SR, Liu BA, et al. Gender differences in adverse drug reactions. J Clin Pharmacol. 1998;38:1003–1009.
   PubMed Web of Science ®Google Scholar
• Johnell K, Klarin I. The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf. 2007;30:911–918.
   PubMed Web of Science ®Google Scholar
• Mjorndal T, Boman MD, Hagg S, et al. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11:65–72.
   PubMed Web of Science ®Google Scholar
• Aronson JK. Polypharmacy, appropriate and inappropriate. Br J Gen Pract. 2006;56:484–485.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209.
   PubMed Web of Science ®Google Scholar
• Barry D, Pietrzak RH, Petry NM. Gender differences in associations between body mass index and DSM-IV mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Ann Epidemiol. 2008;18:458–466.
   PubMed Web of Science ®Google Scholar
• Grover VP, Keel PK, Mitchell JP. Gender differences in implicit weight identity. Int J Eat Disord. 2003;34:125–135.
   PubMed Web of Science ®Google Scholar
• McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106:127–133.
   PubMed Web of Science ®Google Scholar
• Bair MJ, Robinson RL, Katon W, et al. Depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433–2445.
   PubMed Web of Science ®Google Scholar
• Munce SE, Stewart DE. Gender differences in depression and chronic pain conditions in a national epidemiologic survey. Psychosomatics. 2007;48:394–399.
   PubMed Web of Science ®Google Scholar
• Fillingim RB. Sex, gender, and pain: women and men really are different. Curr Rev Pain. 2000;4:24–30.
   PubMedGoogle Scholar
• Fillingim RB, King CD, Ribeiro-Dasilva MC, et al. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain. 2009;10:447–485.
   PubMed Web of Science ®Google Scholar
• Anderson RJ, Freedland KE, Clouse RE, et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–1078.
   PubMed Web of Science ®Google Scholar
• Trento M, Trevisan M, Raballo M, et al. Depression, anxiety, cognitive impairment and their association with clinical and demographic variables in people with type 2 diabetes: a 4-year prospective study. J Endocrinol Invest. 2014;37:79–85.
   PubMed Web of Science ®Google Scholar
• Gonzalez JS, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–2403.
   PubMed Web of Science ®Google Scholar
• Lin EH, Katon W, Von Korff M, et al. Relationship of depression and diabetes self-care, medication adherence, and preventive care. Diabetes Care. 2004;27:2154–2160.
   PubMed Web of Science ®Google Scholar
• Gao YH, Zhao HS, Zhang FR, et al. The relationship between depression and asthma: a meta-analysis of prospective studies. PloS One. 2015;10:e0132424–26197472. PubMed PMID: Pubmed Central PMCID: 4510436.
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Jacobi F, Thefeld W. Mental disorders and asthma in the community. Arch Gen Psychiatry. 2003;60:1125–1130.
   PubMed Web of Science ®Google Scholar
• Belloch A, Perpina M, Martinez-Moragon E, et al. Gender differences in health-related quality of life among patients with asthma. J Asthma. 2003;40:945–953.
   PubMed Web of Science ®Google Scholar
• Sundberg R, Toren K, Franklin KA, et al. Asthma in men and women: treatment adherence, anxiety, and quality of sleep. Respir Med. 2010;104:337–344.
   PubMed Web of Science ®Google Scholar
• Cluley S, Cochrane GM. Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med. 2001;95:37–39.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617–627.
   PubMed Web of Science ®Google Scholar
• Reijnders JS, Ehrt U, Weber WE, et al. A systematic review of prevalence studies of depression in Parkinson's disease. Mov Disord. 2008;23:183–189.
   PubMed Web of Science ®Google Scholar
• Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54:388–398.
   PubMed Web of Science ®Google Scholar
• Murphy JM, Horton NJ, Laird NM, et al. Anxiety and depression: a 40-year perspective on relationships regarding prevalence, distribution, and comorbidity. Acta Psychiatr Scand. 2004;109:355–375.
   PubMed Web of Science ®Google Scholar
• McLean CP, Asnaani A, Litz BT, et al. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45:1027–1035.
   PubMed Web of Science ®Google Scholar
• Barankin B, DeKoven J. Psychosocial effect of common skin diseases. Can Fam Physician. 2002;48:712–716.
   PubMed Web of Science ®Google Scholar
• Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672–676.
   PubMed Web of Science ®Google Scholar
• Zachariae R, Zachariae C, Ibsen HH, et al. Psychological symptoms and quality of life of dermatology outpatients and hospitalized dermatology patients. Acta Dermato-Venereologica. 2004;84:205–212.
   PubMed Web of Science ®Google Scholar
• Picardi A, Abeni D, Melchi CF, et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol. 2000;143:983–991.
   PubMed Web of Science ®Google Scholar
• Ginsburg IH. The psychosocial impact of skin disease. An overview. Dermatol Clin. 1996;14:473–484.
   PubMed Web of Science ®Google Scholar